Global Ophthalmology Surgical Devices Market: Snapshot
Ophthalmology surgical devices are systems, products, and consumables used in retinal, refractive and cataract surgeries and for the diagnosis and effective treatment of eye diseases. These devices include intraocular lenses (IOLs), ophthalmic viscoelastic devices (OVDs), glaucoma drainage systems, excimer laser systems, femtosecond laser solutions, and consumables. The global ophthalmology surgical devices market was valued at around US$ 7.0 Bn in 2016 and is expected to expand at a CAGR of over 4.0% from 2017 to 2025, to reach value of around US$ 11.0 Bn by 2025. Rising elderly population worldwide is expected to contribute to increase in the number of people with avoidable blindness. This, in turn, is projected to drive the global ophthalmology surgical devices market from 2017 to 2025.
A major contributor to growth of the ophthalmology surgical devices market is rising burden of eye disorders across the world. Globally, disorders such as cataract, glaucoma, and age-related macular degeneration (AMD) are the leading causes of blindness and visual impairment. According to a report published by the World Health Organization (WHO) in 2010, cataract was responsible for causing blindness in 20 million people across the globe, which represented around 51% of the world blindness. Glaucoma was estimated to cause blindness in 4.5 million people, which accounted for around 12% of the global blindness. In addition, AMD was the third leading cause of blindness with worldwide prevalence rate of 8.7%. The growing burden of these eye conditions coupled with rising elderly population is expected to increase the need for corrective surgeries in the near future, subsequently stimulating the need for devices and systems used in these surgeries. Another key factor driving the market is several initiatives launched by countries as well as multilateral organizations for eradicating blindness. The Action Plan for Global Eye Health 2014–2019 proposes to decrease avoidable visual impairment considering it as a public health issue and to provide the visually impaired with access to rehabilitation services. As per the action plan, multilateral organizations along with their member states have set a target of reducing the number of patients with avoidable visual impairment by 25% by 2019, from the baseline established by the WHO in 2010. Additionally, high unmet needs for refractive surgeries led by the large number of patients with myopia or short-sightedness are also expected to fuel the market during the forecast period. As per a report published in the ‘Ophthalmology’ journal, around 30% of the global population is myopic or short-sighted currently and it is projected to increase to 50% of the global population (around 5 billion) by 2050. On the flip side, high costs (particularly of ophthalmic laser treatments) and high risks associated with ophthalmic surgery are projected to hamper the market during the forecast period. Technological advancements in surgeries such as cataract and glaucoma have led to increased safety and efficacy of these surgeries. This has helped improve patients’ acceptance of these treatment options. Also, launch of new ophthalmology surgical devices by major manufacturers is projected to create new growth avenues for the market in the next few years.
The global ophthalmology surgical devices market has been segmented based on product, end-user, and geography. Among products, the cataract surgery devices segment is estimated to dominate the market during the forecast period. The leading share held by the segment is attributable to high prevalence of cataract across the globe. Among end-users, hospitals was the largest segment in 2016 and is anticipated to marginally gain market share by 2025. This is attributable to presence of the large number of hospitals, use of technologically advanced safety products, and favorable health care insurance coverage.
Request Sample of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=41633
Geographically, North America held a major share of the global ophthalmology surgical devices market, in terms of revenue, in 2016. The trend is projected to continue from 2017 to 2025, primarily due to large pool of patients with eye disorders and the larger number of patients undergoing eye surgeries in North America than other regions. Additionally, the government support in the form of additional funding for research & development of ophthalmology surgical devices is anticipated to help the region retain its dominance throughout the forecast period. The Asia Pacific market is expected to register a significant growth rate during the forecast period, due to increased participation by local governments in the region in improving health care infrastructure and risen initiatives in the region for eradicating factors causing avoidable blindness.
Major players operating in the global ophthalmology surgical devices market are Alcon, Bausch & Lomb, Carl Zeiss Meditec AG, Glaukos Corporation, HOYA Corporation, IRIDEX Corporation, Johnson & Johnson Vision Care, Inc., Lumenis Ltd., Inc., NIDEK CO., LTD., and STAAR Surgical Company. Manufacturers of ophthalmology surgical devices can focus on strategic collaboration agreements. This would help them penetrate largely untapped markets in developing countries that have large patient population with eye disorders but less access to proper treatment options. Developing innovative technologies that help in reducing the cost of treatment incurred for eye surgeries, which is a high barrier for patients in developing countries, can help in addressing high unmet needs in these countries and also, in reducing the socio-economic burden associated with blindness.